Related Experiment Video
Updated: May 9, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Published on: August 29, 2016
The phylogeny of permanent prostate brachytherapy
Jesse N Aronowitz1, Mark J Rivard
1Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA.
Modern prostate brachytherapy techniques evolved from earlier procedures. Continuous re-evaluation of current methods is essential to maximize the potential of this safe and effective prostate cancer treatment.
Area of Science:
- Oncology
- Medical Physics
- Urology
Background:
- Permanent prostate brachytherapy has a history spanning over a century.
- Current transperineal ultrasound-directed techniques have roots in earlier procedures.
- Historical practices may influence contemporary treatment protocols.
Purpose of the Study:
- To review the historical evolution of permanent prostate brachytherapy.
- To assess the influence of earlier techniques on modern transperineal brachytherapy.
- To identify areas for continuous improvement in prostate brachytherapy.
Main Methods:
- A comprehensive literature review was conducted.
- Historical data on prostate brachytherapy procedures were analyzed.
- Current clinical practices were examined in the context of their origins.
Main Results:
- Key aspects of modern brachytherapy, including seed dimensions, prescribed dose, and treatment sequencing, may be suboptimal.
- These features are considered vestigial, potentially not optimized for current technology.
- Modern transperineal permanent prostate implants are safe and effective.
Conclusions:
- The established practices in permanent prostate brachytherapy warrant ongoing critical assessment.
- Continuous re-evaluation and adaptation are necessary to optimize treatment outcomes.
- Further evolution of the transperineal ultrasound-directed technique is recommended.
More Related Videos
07:34Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018